These SNPs are alleged to be involved in the development of cancer, especially CRC, by altering MTHFR activity, which in turn reduces the silencing of tumour suppressor genes and increases the availability of nucleotides for DNA synthesis and repair, thereby protecting against early-onset cancer in LS15,21. The gene discussed is MTHFR; the disease is Onset.